Ellison LF. Progress in net cancer survival in Canada over 20 years. Health Rep. 2018;29(9):10–8.
Hurton S, MacDonald F, Porter G, Walsh M, Molinari M. The current state of pancreatic cancer in Canada: incidence, mortality, and surgical therapy. Pancreas. 2014;43(6):879–85.
Higuera O, Ghanem I, Nasimi R, Prieto I, Koren L, Feliu J. Management of pancreatic cancer in the elderly. World J Gastroenterol. 2016;22(2):764.
Macchini M, Chiaravalli M, Zanon S, Peretti U, Mazza E, Gianni L, et al. Chemotherapy in elderly patients with pancreatic cancer: Efficacy, feasibility and future perspectives. Cancer Treat Rev. 2019;72:1–6.
Kanji ZS, Gallinger S. Diagnosis and management of pancreatic cancer. Cmaj. 2013;185(14):1219–26.
O’Reilly D, Fou L, Hasler E, Hawkins J, O’Connell S, Pelone F, et al. Diagnosis and management of pancreatic cancer in adults: A summary of guidelines from the UK National Institute for Health and Care Excellence. Pancreatology. 2018;18(8):962–70.
Tempero MA. NCCN guidelines updates: pancreatic cancer. J Natl Compr Cancer Netw. 2019;17(5.5):603–5.
Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol. 2009;27(17):2758–65.
Scher KS, Hurria A. Under-representation of older adults in cancer registration trials: known problem, little progress. J Clin Oncol. 2012;30(17):2036–8.
Talarico L, Chen G, Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol. 2004;22(22):4626–31.
Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341(27):2061–7.
Williams GR, Mackenzie A, Magnuson A, Olin R, Chapman A, Mohile S, et al. Comorbidity in older adults with cancer. J Geriatr Oncol. 2016;7(4):249–57.
Berry SD, Ngo L, Samelson EJ, Kiel DP. Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc. 2010;58(4):783–7.
Mavros MN, Coburn NG, Davis LE, Mahar AL, Liu Y, Beyfuss K, et al. Low rates of specialized cancer consultation and cancer-directed therapy for noncurable pancreatic adenocarcinoma: a population-based analysis. CMAJ. 2019;191(21):E574–80.
Burdett N, Vincent AD, O’Callaghan M, Kichenadasse G. Competing risks in older patients with cancer: a systematic review of geriatric oncology trials. JNCI. 2018;110(8):825–30.
Jang RW, Krzyzanowska MK, Zimmermann C, Taback N, Alibhai SM. Palliative care and the aggressiveness of end-of-life care in patients with advanced pancreatic cancer. J Natl Cancer Inst. 2015;107(3):dju424.
Tanuseputro P, Wodchis WP, Fowler R, Walker P, Bai YQ, Bronskill SE, et al. The health care cost of dying: a population-based retrospective cohort study of the last year of life in Ontario, Canada. PLoS One. 2015;10(3):e0121759.
Kelly EM, James PD, Murthy S, Antonova L, Wong F, Shaw-Stiffel T, et al. Health care utilization and costs for patients with end-stage liver disease are significantly higher at the end of life compared to those of other decedents. Clin Gastroenterol Hepatol. 2019;17(11):2339–46.
Quinn KL, Stukel T, Stall NM, Huang A, Isenberg S, Tanuseputro P, et al. Association between palliative care and healthcare outcomes among adults with terminal non-cancer illness: population based matched cohort study. BMJ. 2020;370:m2257.
Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.
Clarke E, Marrett L, Kreiger N. Cancer registration in Ontario: a computer approach. IARC Sci Publ. 1991;95:246–57.
Robles SC, Marrett LD, Clarke EA, Risch HA. An application of capture-recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988;41(5):495–501.
Government of Ontario. Registered Persons Database. data.ontario.ca. [cited 2020 Nov 25]. Available from: https://data.ontario.ca/dataset/registered-persons-database-rpdb
Library and Archives Canada. Births, Marriages, and Deaths Recorded in Canada. bac-lac.gc.ca. [cited 2020 Nov 25]. Available from: https://www.bac-lac.gc.ca/eng/discover/vital-statistics-births-marriages-deaths/births-marriages-deaths-recorded/Pages/births-marriages-deaths-recorded.aspx#b
Government of Ontario. Health Care in Ontario. Ontario.ca. [cited 2020 Nov 25]. Available from: https://www.ontario.ca/page/health-care-ontario
Canadian Institute for Health Information. Discharge Abstract Data metadata. cihi.ca. [cited 2020 Nov 25]. Available from: https://www.cihi.ca/en/discharge-abstract-database-metadata-dad
ICES. Data Dictionary: SDS. datadictionary.ices.on.ca. 2022 [cited 2022 Apr 2]. Available from: https://datadictionary.ices.on.ca/Applications/DataDictionary/Library.aspx?Library=SDS
Cancer Care Ontario’s Data Book - 2018-2019. I. Cancer Activity Level Reporting (ALR). cancercareontario.ca. [cited 2022 Mar 31]. Available from: https://ext.cancercare.on.ca/ext/databook/db1819/I-_Activity_Level_Reporting_ALR/Introduction.htm
Canadian Institute for Health Information. National Ambulatory Care Reporting System metadata (NACRS). cihi.ca. [cited 2020 Nov 25]. Available from: https://www.cihi.ca/en/national-ambulatory-care-reporting-system-metadata-nacrs
Canadian Institute for Health Information. National Rehabiliation Reporting System. cihi.ca. 2021 [cited 2022 Apr 4]. Available from: https://www.cihi.ca/en/national-rehabilitation-reporting-system-metadata
Canadian Institute for Health Information. Continuing Care Reporting System. cihi.ca. [cited 2020 Dec 13]. Available from: https://www.cihi.ca/en/continuing-care
The InterRAI Organization. InterRAI. interrai.org. [cited 2020 Dec 13]. Available from: https://www.interrai.org/
Canadian Institute for Health Information. Home Care. cihi.ca. [cited 2020 Dec 13]. Available from: https://www.cihi.ca/en/home-care
Health Quality Ontario. Measuring Home Care Performance in Ontario. hqontario.ca. [cited 2020 Dec 13]. Available from: https://hqontario.ca/System-Performance/Measuring-System-Performance/Measuring-Home-Care
World Health Organization. The International Statistical Classification of Diseases and Health Related Problems ICD-10: Tenth Revision. Volume 1: Tabular List. Vol. 1. https://www.who.int/. [cited 2020 Dec 13]. Available from: https://apps.who.int/iris/bitstream/handle/10665/42980/9241546530_eng.pdf?sequence=1&isAllowed=y.
Booth CM, Nanji S, Wei X, Peng Y, Biagi JJ, Hanna TP, et al. Use and effectiveness of adjuvant chemotherapy for stage III colon cancer: a population-based study. J Natl Compr Cancer Netw. 2016;14(1):47–56.
Leveridge MJ, Siemens DR, Mackillop WJ, Peng Y, Tannock IF, Berman DM, et al. Radical cystectomy and adjuvant chemotherapy for bladder cancer in the elderly: a population-based study. Urology. 2015;85(4):791–8.
Nam RK, Cheung P, Herschorn S, Saskin R, Su J, Klotz LH, et al. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study. Lancet Oncol. 2014;15(2):223–31.
Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–51.
Pefoyo AJK, Bronskill SE, Gruneir A, Calzavara A, Thavorn K, Petrosyan Y, et al. The increasing burden and complexity of multimorbidity. BMC Public Health. 2015;15(1):1–11.
Thavorn K, Maxwell CJ, Gruneir A, Bronskill SE, Bai Y, Pefoyo AJK, et al. Effect of socio-demographic factors on the association between multimorbidity and healthcare costs: a population-based, retrospective cohort study. BMJ Open. 2017;7(10):e017264.
Kone AP, Mondor L, Maxwell C, Kabir US, Rosella LC, Wodchis WP. Rising burden of multimorbidity and related socio-demographic factors: a repeated cross-sectional study of Ontarians. Can J Public Health. 2021;112(4):737–47.
Raju R, Coburn N, Liu N, Porter J, Seung S, Cheung M, et al. A population-based study of the epidemiology of pancreatic cancer: a brief report. Curr Oncol. 2015;22(6):478–84.
Wu JW, Azoulay L, Huang A, Paterson M, Wu F, Secrest MH, et al. Identification of incident pancreatic cancer in Ontario administrative health data: A validation study. Pharmacoepidemiol Drug Saf. 2020;29:78–85.
Booth CM, Li G, Zhang-Salomons J, Mackillop WJ. The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer. 2010;116(17):4160–7.
Edge S, Compton C, Fritz A, Greene F, Trotti A, (Editors). American Joint Committee on Cancer. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
Wilkins R. Use of postal codes and addresses in the analysis of health data. Health Rep. 1993;5(2):157–77.
Alter DA, Naylor CD, Austin P, Tu JV. Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med. 1999;341(18):1359–67.
Seow H, O’Leary E, Perez R, Tanuseputro P. Access to palliative care by disease trajectory: a population-based cohort of Ontario decedents. BMJ Open. 2018;8(4):e021147.
Barbera L, Hwee J, Klinger C, Jembere N, Seow H, Pereira J. Identification of the physician workforce providing palliative care in Ontario using administrative claims data. CMAJ Open. 2015;3(3):E292.
Tanuseputro P, Budhwani S, Bai YQ, Wodchis WP. Palliative care delivery across health sectors: a population-level observational study. Palliat Med. 2017;31(3):247–57.
Merchant SJ, Brogly SB, Goldie C, Booth CM, Nanji S, Patel SV, et al. Palliative care is associated with reduced aggressive end-of-life care in patients with gastrointestinal cancer. Ann Surg Oncol. 2018;25(6):1478–87.
Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008;26(23):3860.
Ho TH, Barbera L, Saskin R, Lu H, Neville BA, Earle CC. Trends in the aggressiveness of end-of-life cancer care in the universal health care system of Ontario, Canada. J Clin Oncol. 2011;29(12):1587.
Merchant SJ, Lajkosz K, Brogly SB, Booth CM, Nanji S, Patel SV, et al. The final 30 days of life: a study of patients with gastrointestinal cancer in Ontario, Canada. J Palliat Care. 2017;32(3–4):92–100.
Henselmans I, Van Laarhoven HW, Van der Vloodt J, De Haes HC, Smets EM. Shared decision making about palliative chemotherapy: a qualitative observation of talk about patients’ preferences. Palliat Med. 2017;31(7):625–33.
Conroy T, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–25.
Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691–703.
Perinel J, Adham M. Palliative therapy in pancreatic cancer—palliative surgery. Transl Gastroenterol Hepatol. 2019;4:28.
Simunovic M, Urbach D, Major D, Sutradhar R, Baxter N, To T, et al. Assessing the volume-outcome hypothesis and region-level quality improvement interventions: pancreas cancer surgery in two Canadian Provinces. Ann Surg Oncol. 2010;17(10):2537–44.
Schroeder MC, Chapman CG, Nattinger MC, Halfdanarson TR, Abu-Hejleh T, Tien YY, et al. Variation in geographic access to chemotherapy by definitions of providers and service locations: a population-based observational study. BMC Health Serv Res. 2016;16(1):1–8.
Bao Y, Maciejewski RC, Garrido MM, Shah MA, Maciejewski PK, Prigerson HG. Chemotherapy use, end-of-life care, and costs of care among patients diagnosed with stage IV pancreatic cancer. J Pain Symptom Manag. 2018;55(4):1113–21.
Lees C, Weerasinghe S, Lamond N, Younis T, Ramjeesingh R. Palliative care consultation and aggressive care at end of life in unresectable pancreatic cancer. Curr Oncol. 2019;26(1):28–36.
Mack JW, Cronin A, Keating NL, Taback N, Huskamp HA, Malin JL, et al. Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol. 2012;30(35):4387.
Sheffield KM, Boyd CA, Benarroch-Gampel J, Kuo Y, Cooksley CD, Riall TS. End-of-life care in Medicare beneficiaries dying with pancreatic cancer. Cancer. 2011;117(21):5003–12.
Faluyi OO, Connor JL, Chatterjee M, Ikin C, Wong H, Palmer DH. Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre. Br J Cancer. 2017;116(4):424–31.
Ullgren H, Fransson P, Olofsson A, Segersvärd R, Sharp L. Health care utilization at end of life among patients with lung or pancreatic cancer. Comparison between two Swedish cohorts. PLoS One. 2021;16(7):e0254673.